Rybelsus N 4 mg, Tabletten

7680698650034 CH-69865 Tabletten

Associated product:

RYBELSUS N cpr 4 mg 90 pce

No image available

Article details

Package size
90
Selling units
90
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/09/2026
Patient information leaflet
Français
01/09/2026
Patient information leaflet
Italien
01/09/2026
Summary of Product Characteristics
Allemand
01/09/2026
Summary of Product Characteristics
Français
01/09/2026
Summary of Product Characteristics
Italien
01/09/2026

Detailed composition

Substance Quantity Type Category
semaglutidum
4.0 MG Substance Wirkstoff (Principe actif)
natrii salcaprozas
- Substance HNIDK
natrium
8.0 MG Substance HBESI
magnesii stearas
- Substance HNIDK

Reimbursement information

Public price
CHF 307.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
69865
Drug name
Rybelsus N, Tabletten
Galenic form
TAB
ATC Code
A10BJ06
Authorization status
Z
Dispensing category
B
First authorization
28/11/2025
Authorization expiration date
27/11/2030
IT Number
07.06.2.
Domain
Human medicine
Field of application
Diabetes mellitus Typ 2, Reduktion des Risikos schwerwiegender kardiovaskulärer Ereignisse

Package details

Description (FR)
RYBELSUS N cpr 4 mg 90 pce
Description (DE)
RYBELSUS N Tabl 4 mg 90 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Other package sizes (4)

RYBELSUS N cpr 1.5 mg 30 pce
30 TABL
GTIN: 7680698650010
View
RYBELSUS N cpr 4 mg 30 pce
30 TABL
GTIN: 7680698650027
View
RYBELSUS N cpr 9 mg 30 pce
30 TABL
GTIN: 7680698650041
View
RYBELSUS N cpr 9 mg 90 pce
90 TABL
GTIN: 7680698650058
View
Buy us a coffee Explore the data